The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19
Antibody therapies such as convalescent plasma and monoclonal antibodies have emerged as major potential therapeutics for coronavirus disease 2019 (COVID-19). Immunoglobulins differ from conventional antimicrobial agents in that they mediate direct and indirect antimicrobial effects that work in co...
Saved in:
Main Authors: | Arturo Casadevall, Liise-anne Pirofski, Michael J. Joyner |
---|---|
Format: | article |
Language: | EN |
Published: |
American Society for Microbiology
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/8c5b8ee90d8c4f3eb4d30df870e01f9a |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pathogenesis of COVID-19 from the Perspective of the Damage-Response Framework
by: Liise-anne Pirofski, et al.
Published: (2020) -
Immune-Mediated Damage Completes the Parabola: <italic toggle="yes">Cryptococcus neoformans</italic> Pathogenesis Can Reflect the Outcome of a Weak or Strong Immune Response
by: Liise-anne Pirofski, et al.
Published: (2017) -
Benefits and Costs of Animal Virulence for Microbes
by: Arturo Casadevall, et al.
Published: (2019) -
Reduction of <named-content content-type="genus-species">Streptococcus pneumoniae</named-content> Colonization and Dissemination by a Nonopsonic Capsular Polysaccharide Antibody
by: Christopher R. Doyle, et al.
Published: (2016) -
Antibodies to <named-content content-type="genus-species">Streptococcus pneumoniae</named-content> Capsular Polysaccharide Enhance Pneumococcal Quorum Sensing
by: Masahide Yano, et al.
Published: (2011)